Aspirin dosing after acute coronary syndrome with suspected aspirin resistance: the ANDAMAN trial
European Heart Journal

Abstract
Despite current antithrombotic treatments, the recurrence of ischaemic events remains high in patients with diabetes mellitus (DM) or aspirin resistance after acute coronary syndrome (ACS). Whether twice-daily aspirin dosing reduces major adverse cardiovascular events (MACE) in this population remains unknown.
In this prospective multicentre, randomized trial, patients with ACS and DM or high-risk of aspirin resistance (HRAR) defined as: (i) an index event occurring while on aspirin; (ii) body mass index ≥27 kg/m2; or (iii) increased waist circumference were assigned to receive enteric-coated aspirin once daily (100 mg/day) or twice daily (100 mg morning and evening). The primary outcome was MACE, a composite of any death, myocardial infarction, stroke, urgent coronary revascularization, stent thrombosis, or acute arterial thrombotic event assessed using a time-to-first-event analysis. The main secondary outcome was major bleeding (Bleeding Academic Research Consortium type 3–5).
In total, 2484 participants were enrolled (77.2% with DM, 55.5% with ST-elevation segment myocardial infarction). The median follow-up duration was 18 (interquartile range: 17.6–18.3) months. The primary outcome occurred in 95 of 1228 participants (7.7%) in the twice-daily aspirin group, and 110 of 1256 (8.8%) in the once-daily group (hazard ratio [HR] 0.90; 95% confidence interval [CI] 0.69–1.19;
In patients with ACS and DM or HRAR, twice-daily aspirin did not significantly reduce the risk of MACE compared to once-daily dosing. No significant difference was observed in major bleeding between groups.
NCT02520921/EUDRACT No: 2015-000947-18.
Contributors

Patrick Henry
Author

Jean-Guillaume Dillinger
Author

Aboyans Victor
Author

Théo Pezel
Author

Angoulvant Denis
Author

Laure Batias
Author

Batias Laure
Author

Denis Angoulvant
Author

Belle Loic
Author

Marc Goralski
Author

Emile Ferrari
Author

Bellemain-Appaix Anne
Author

Guillaume Cayla
Author

Benamer Hakim
Author

Beygui Farzin
Author

Johanne Silvain
Author

Martine Gilard
Author

Bihry Nicolas
Author

Gilles Lemesle
Author

Géraud Souteyrand
Author

Pascal Lim
Author

François Roubille
Author

Bonnefoy-Cudraz Eric
Author

Jean-Louis Georges
Author

Claire Bal dit Sollier
Author

Thibaut Petroni
Author

Brunel Philippe
Author

Carrie Didier
Author

Cayla Guillaume
Author

Olivier Morel
Author

Chague Frédéric
Author

Nicolas Delarche
Author

Meier Elbaz
Author

Coste Pierre
Author

Cottin Yves
Author

Solenn Toupin
Author

Cuisset Thomas
Author

Delarche Nicolas
Author

Derimay François
Author

Gilles Montalescot
Author

Ludovic Drouet
Author

Eric Vicaut
Author

Dib Jean Claude
Author

Dillinger Jean-Guillaume
Author

Ducrocq Gregory
Author

Elbaz Meyer
Author

Ferrari Emile
Author

Georges Jean-Louis
Author

Gilard Martine
Author

Goralski Marc
Author

Goube Pascal
Author

Hauguel-Moreau Marie
Author

Henry Patrick
Author

Houssany-Pissot Sonia
Author

Lebreton Hervé
Author

Lemesle Gilles
Author

Lim Pascal
Author

Maillard Loic
Author

Mitchell-Heggs Laurens
Author

Montalescot Gilles
Author

Morel Olivier
Author

Petroni Thibault
Author

Pezel Théo
Author

Prunier Fabrice
Author

Puymirat Etienne
Author

Roubille François
Author

Sanguineti Francesca
Author

Schiele François
Author

Silvain Johanne
Author

Souteyrand Geraud
Author

Steg Philippe Gabriel
Author

Tron Christophe
Author

Varenne Olivier
Author

